Your browser doesn't support javascript.
loading
The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.
Holte, Harald; Beiske, Klaus; Boyle, Merrill; Trøen, Gunhild; Blaker, Yngvild N; Myklebust, June; Kvaløy, Sunniva; Rosenwald, Andreas; Lingjaerde, Ole C; Rimsza, Lisa M; Smeland, Erlend B; Scott, David W; Kolstad, Arne.
Afiliación
  • Holte H; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Beiske K; KG Jebsen Centre for B cell malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
  • Boyle M; Department of Pathology, Oslo University Hospital, Oslo, Norway.
  • Trøen G; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Blaker YN; Department of Pathology, Oslo University Hospital, Oslo, Norway.
  • Myklebust J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Kvaløy S; KG Jebsen Centre for B cell malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
  • Rosenwald A; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Lingjaerde OC; Department of Surgery, Vestfold Hospital Trust, Oslo, Norway.
  • Rimsza LM; Institute of Pathology, University of Würzburg and Comprehensive Cancer Centre (CCC) Mainfranken, Würzburg, Germany.
  • Smeland EB; Department of Informatics, University of Oslo, Oslo, Norway.
  • Scott DW; Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.
  • Kolstad A; KG Jebsen Centre for B cell malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Br J Haematol ; 183(2): 225-234, 2018 10.
Article en En | MEDLINE | ID: mdl-30080252
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células del Manto Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células del Manto Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido